Clinical Trial Update: Citicoline in Ischemic Stroke, a Randomized Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating citicoline for ischemic stroke has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED